Early safety check: how new heart drug mixes with common meds
NCT ID NCT06979973
Summary
This early-stage study aims to understand how an experimental heart drug called CKD-508 interacts with two common medications (midazolam and rosuvastatin) in the body. It involved 24 healthy adult male volunteers to measure drug levels and check for safety. The goal is to gather basic information about potential drug interactions before testing CKD-508 in patients with heart conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.